The role of adipocytokines in atherogenesis and atheroprogression.
暂无分享,去创建一个
[1] T. W. Smith,et al. Fatty acid binding protein 4 expression in cerebral vascular malformations: implications for vascular remodelling , 2015, Neuropathology and applied neurobiology.
[2] Y. Qi,et al. Possible role of fibroblast growth factor 21 on atherosclerosis via amelioration of endoplasmic reticulum stress-mediated apoptosis in apoE−/− mice , 2015, Heart and Vessels.
[3] Fei Li,et al. Involvement of RBP4 in hyperinsulinism-induced vascular smooth muscle cell proliferation , 2015, Endocrine.
[4] H. Oflaz,et al. Serum Omentin 1 Level Is Associated With Coronary Artery Disease and Its Severity in Postmenopausal Women , 2014, Angiology.
[5] S. Younespour,et al. Increased serum leptin and resistin levels and increased carotid intima-media wall thickness in patients with psoriasis: is psoriasis associated with atherosclerosis? , 2014, Journal of the American Academy of Dermatology.
[6] J. Furness,et al. Novel and Conventional Receptors for Ghrelin, Desacyl-Ghrelin, and Pharmacologically Related Compounds , 2014, Pharmacological Reviews.
[7] D. Mozaffarian,et al. Plasma-free fatty acids, fatty acid-binding protein 4, and mortality in older adults (from the Cardiovascular Health Study). , 2014, The American journal of cardiology.
[8] J. Hata,et al. Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke - Research for Biomarkers in Ischemic Stroke (REBIOS). , 2014, Metabolism: clinical and experimental.
[9] J. Lekakis,et al. Omentin, fat and heart: classical music with new instruments. , 2014, Heart, lung & circulation.
[10] Jason L. Johnson. Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis. , 2014, Cardiovascular research.
[11] K. Kohara,et al. Clinical characteristics of high plasma adiponectin and high plasma leptin as risk factors for arterial stiffness and related end-organ damage. , 2014, Atherosclerosis.
[12] K. Nikita,et al. The relationship of novel adipokines, RBP4 and omentin-1, with carotid atherosclerosis severity and vulnerability. , 2014, Atherosclerosis.
[13] J. Tune,et al. Perivascular Adipose Tissue and Coronary Vascular Disease , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[14] A. Arbor,et al. Perivascular adipose tissue in vascular function and disease: a review of current research and animal models. , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[15] Increased Hs-CRP/adiponectin ratio is associated with increase carotid intima-media thickness , 2014, Lipids in Health and Disease.
[16] N. Itoh. FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases , 2014, Front. Endocrinol..
[17] G. Dimitriadis,et al. Serum levels of novel adipokines in patients with acute ischemic stroke: Potential contribution to diagnosis and prognosis , 2014, Peptides.
[18] F. Wang,et al. Inhibition of leptin-induced vascular extracellular matrix remodelling by adiponectin , 2014, Journal of molecular endocrinology.
[19] T. Murohara,et al. Association of Circulating C1q/TNF-Related Protein 1 Levels with Coronary Artery Disease in Men , 2014, PloS one.
[20] R. Virmani,et al. Mechanisms of Plaque Formation and Rupture , 2014 .
[21] P. Davis,et al. Increased RBP4 in a human model of activated anti‐atherosclerotic and antiremodelling defences , 2014, European journal of clinical investigation.
[22] O. Topaloglu,et al. Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome. , 2014, Minerva endocrinologica.
[23] P. Vokonas,et al. Chemerin levels as predictor of acute coronary events: a case-control study nested within the veterans affairs normative aging study. , 2014, Metabolism: clinical and experimental.
[24] G. Randolph. Mechanisms that regulate macrophage burden in atherosclerosis. , 2014, Circulation research.
[25] A. Tedgui,et al. Adaptive (T and B Cells) Immunity and Control by Dendritic Cells in Atherosclerosis , 2014, Circulation research.
[26] Viorel Simion,et al. Subendothelial resistin enhances monocyte transmigration in a co-culture of human endothelial and smooth muscle cells by mechanisms involving fractalkine, MCP-1 and activation of TLR4 and Gi/o proteins signaling. , 2014, The international journal of biochemistry & cell biology.
[27] K. Kario,et al. Circulating des-acyl ghrelin improves cardiovascular risk prediction in older hypertensive patients. , 2014, American journal of hypertension.
[28] J. Kellum,et al. Follistatin‐like protein 1 enhances NLRP3 inflammasome‐mediated IL‐1β secretion from monocytes and macrophages , 2014, European journal of immunology.
[29] J. Zhan,et al. Adiponectin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the AMPK/mTOR pathway. , 2014, Experimental cell research.
[30] H. Papadaki,et al. Chemerin and CMKLR1 expression in human arteries and periadventitial fat: a possible role for local chemerin in atherosclerosis? , 2014, BMC Cardiovascular Disorders.
[31] M. Febbraio,et al. From cytokine to myokine: the emerging role of interleukin‐6 in metabolic regulation , 2014, Immunology and cell biology.
[32] Jeong Mi Seo,et al. Visfatin contributes to the differentiation of monocytes into macrophages through the differential regulation of inflammatory cytokines in THP-1 cells. , 2014, Cellular signalling.
[33] B. Cheung,et al. Deamidated Lipocalin‐2 Induces Endothelial Dysfunction and Hypertension in Dietary Obese Mice , 2014, Journal of the American Heart Association.
[34] A. León,et al. The association of resistin with coronary disease in the general population. , 2014 .
[35] P. Dessein,et al. Retinol Binding Protein 4 Concentrations Relate to Enhanced Atherosclerosis in Obese Patients with Rheumatoid Arthritis , 2014, PLoS ONE.
[36] Fei Li,et al. Retinol binding protein 4 promotes hyperinsulinism-induced proliferation of rat aortic smooth muscle cells , 2014, Molecular medicine reports.
[37] G. Ho,et al. Serum leptin levels positively correlate with peripheral arterial stiffness in kidney transplantation patients. , 2014, Transplantation proceedings.
[38] Y. Fukumoto,et al. Serum vaspin levels are positively associated with carotid atherosclerosis in a general population. , 2014, Atherosclerosis.
[39] M. Sperandio,et al. Endothelial Cell–Derived Chemerin Promotes Dendritic Cell Transmigration , 2014, The Journal of Immunology.
[40] Vinícius Andrade-Oliveira,et al. Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells , 2014, European journal of immunology.
[41] B. Zabel,et al. Chemerin regulation and role in host defense. , 2014, American journal of clinical and experimental immunology.
[42] Lei Xiao,et al. New paradigms in inflammatory signaling in vascular endothelial cells. , 2014, American journal of physiology. Heart and circulatory physiology.
[43] Hongyu Peng,et al. [Impact of exogenous fibroblast growth factor 21 on atherosclerosis in apolipoprotein E deficient mice]. , 2014, Zhonghua xin xue guan bing za zhi.
[44] Ling-Qing Yuan,et al. Leptin promotes the osteoblastic differentiation of vascular smooth muscle cells from female mice by increasing RANKL expression. , 2014, Endocrinology.
[45] A. Lapucci,et al. Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes , 2014, Immunology and cell biology.
[46] Haiming Cao. Adipocytokines in obesity and metabolic disease. , 2014, The Journal of endocrinology.
[47] M. Schulze,et al. Adiponectin and Risk of Stroke: Prospective Study and Meta-analysis , 2014, Stroke.
[48] A. Ballestrero,et al. Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice , 2013, Thrombosis and Haemostasis.
[49] A. Fontana,et al. Serum Resistin, Cardiovascular Disease and All-Cause Mortality in Patients with Type 2 Diabetes , 2013, PloS one.
[50] Yingfang Zhou,et al. Apelin: a potential marker of coronary artery stenosis and atherosclerotic plaque stability in ACS patients. , 2014, International heart journal.
[51] Paul Poirier,et al. Overview of epidemiology and contribution of obesity to cardiovascular disease. , 2014, Progress in cardiovascular diseases.
[52] K. Kitamura,et al. Association between adiponectin production in coronary circulation and future cardiovascular events in patients with coronary artery disease. , 2014, International heart journal.
[53] P. Codoñer-Franch,et al. Plasma resistin levels are associated with homocysteine, endothelial activation, and nitrosative stress in obese youths. , 2014, Clinical biochemistry.
[54] Jingang Liu,et al. Bariatric surgery relieves type 2 diabetes and modulates inflammatory factors and coronary endothelium eNOS/iNOS expression in db/db mice. , 2014, Canadian journal of physiology and pharmacology.
[55] N. Weintraub,et al. Proinflammatory phenotype of perivascular adipocytes. , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[56] Hee-Jung Choi,et al. Lipocalin-2 elicited by advanced glycation end-products promotes the migration of vascular smooth muscle cells. , 2013, Biochimica et biophysica acta.
[57] Yongde Peng,et al. Follistatin-Like 1: A Potential Mediator of Inflammation in Obesity , 2013, Mediators of inflammation.
[58] Zhenjie Wu,et al. Association between Adiponectin Concentrations and Cardiovascular Disease in Diabetic Patients: A Systematic Review and Meta-Analysis , 2013, PloS one.
[59] M. Okada,et al. Vaspin prevents methylglyoxal‐induced apoptosis in human vascular endothelial cells by inhibiting reactive oxygen species generation , 2013, Acta physiologica.
[60] A. Orekhov,et al. Vascular Extracellular Matrix in Atherosclerosis , 2013, Cardiology in review.
[61] Amir Lerman,et al. Endothelial dysfunction over the course of coronary artery disease. , 2013, European Heart Journal.
[62] F. Mattace-Raso,et al. Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[63] T. Murohara,et al. Impact of adiponectin and leptin on long-term adverse events in Japanese patients with acute myocardial infarction. Results from the Nagoya Acute Myocardial Infarction Study (NAMIS). , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[64] G. Can,et al. High adiponectin levels fail to protect against the risk of hypertension and, in women, against coronary disease: involvement in autoimmunity? , 2013, World journal of diabetes.
[65] T. Romacho,et al. Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells , 2013, PloS one.
[66] Y. E. Chen,et al. Leptin‐Induced Endothelial Dysfunction Is Mediated by Sympathetic Nervous System Activity , 2013, Journal of the American Heart Association.
[67] P. Neves,et al. What Is the Role of Apelin regarding Cardiovascular Risk and Progression of Renal Disease in Type 2 Diabetic Patients with Diabetic Nephropathy? , 2013, BioMed research international.
[68] E. Sengul,et al. Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease , 2013, Renal failure.
[69] U. Eriksson,et al. Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury. , 2013, Cardiovascular research.
[70] Eugene Kim,et al. Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis. , 2013, International journal of epidemiology.
[71] R. Sacco,et al. Traditional Risk Factors Are Not Major Contributors to the Variance in Carotid Intima-Media Thickness , 2013, Stroke.
[72] H. Aburatani,et al. Resistin-Like Molecule &bgr; Is Abundantly Expressed in Foam Cells and Is Involved in Atherosclerosis Development , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[73] C. Monaco,et al. Biomechanical factors and macrophages in plaque stability. , 2013, Cardiovascular research.
[74] O. Ratib,et al. Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines. , 2013, European heart journal.
[75] A. Yoshida,et al. Adiponectin-induced dilation of isolated porcine retinal arterioles via production of nitric oxide from endothelial cells. , 2013, Investigative ophthalmology & visual science.
[76] M. Xia,et al. Adiponectin increases macrophages cholesterol efflux and suppresses foam cell formation in patients with type 2 diabetes mellitus. , 2013, Atherosclerosis.
[77] L. Kappelle,et al. Adiponectin and incident coronary heart disease and stroke. A systematic review and meta‐analysis of prospective studies , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[78] L. Lipsitz,et al. Adiponectin Levels and the Risk of Hypertension: A Systematic Review and Meta-Analysis , 2013, Hypertension.
[79] E. Ingelsson,et al. Oxidative stress and inflammatory markers in relation to circulating levels of adiponectin , 2013, Obesity.
[80] P. Libby,et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis , 2013, Nature Medicine.
[81] A. Xu,et al. Circulating Lipocalin-2 and Retinol-Binding Protein 4 Are Associated with Intima-Media Thickness and Subclinical Atherosclerosis in Patients with Type 2 Diabetes , 2013, PloS one.
[82] T. Romacho,et al. Visfatin/Nampt: An Adipokine with Cardiovascular Impact , 2013, Mediators of inflammation.
[83] K. Channon,et al. Interactions Between Vascular Wall and Perivascular Adipose Tissue Reveal Novel Roles for Adiponectin in the Regulation of Endothelial Nitric Oxide Synthase Function in Human Vessels , 2013, Circulation.
[84] Weiru Zhang,et al. Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease. , 2013, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.
[85] L. Lind,et al. Leptin and endothelial function in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. , 2013, Atherosclerosis.
[86] Jie Cao,et al. Adiponectin Levels and Risk of Coronary Heart Disease: A Meta-analysis of Prospective Studies , 2013, The American journal of the medical sciences.
[87] J. Scholey,et al. Adiponectin attenuates angiotensin II-induced oxidative stress in renal tubular cells through AMPK and cAMP-Epac signal transduction pathways. , 2013, American journal of physiology. Renal physiology.
[88] N. Leitinger,et al. Phenotypic polarization of macrophages in atherosclerosis. , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[89] H. Vargas-Robles,et al. Correlation between Levels of Circulating Adipokines and Adiponectin/Resistin Index with Carotid Intima-Media Thickness in Hypertensive Type 2 Diabetic Patients , 2013, Cardiology.
[90] Y. Matsuzawa,et al. Serum adiponectin levels predict the risk of coronary heart disease in Japanese patients with type 2 diabetes , 2013, Journal of diabetes investigation.
[91] H. Brenner,et al. Proinflammatory Cytokines, Adiponectin, and Increased Risk of Primary Cardiovascular Events in Diabetic Patients With or Without Renal Dysfunction , 2013, Diabetes Care.
[92] J. Manson,et al. Plasma Retinol-Binding Protein 4 (RBP4) Levels and Risk of Coronary Heart Disease: A Prospective Analysis Among Women in the Nurses’ Health Study , 2013, Circulation.
[93] E. González-Rey,et al. Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells , 2013, Brain, Behavior, and Immunity.
[94] Wei Li,et al. Serum total adiponectin level and the risk of cardiovascular disease in general population: a meta-analysis of 17 prospective studies. , 2013, Atherosclerosis.
[95] J. Eckel,et al. Regulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells , 2013, Archives of physiology and biochemistry.
[96] Zhimin Chen,et al. Associations of Adiponectin and Leptin with Incident Coronary Heart Disease and Ischemic Stroke in African Americans: The Jackson Heart Study , 2013, Front. Public Health.
[97] Dan Yang,et al. Ghrelin protects human pulmonary artery endothelial cells against hypoxia-induced injury via PI3-kinase/Akt , 2013, Peptides.
[98] M. Criqui,et al. HIGHER LEPTIN IS ASSOCIATED WITH HYPERTENSION: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS , 2013, Journal of Human Hypertension.
[99] Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36 , 2013, Cell Stress and Chaperones.
[100] Li-jun Guo,et al. Association between serum resistin level and cardiovascular events in postmenopausal women with acute coronary syndrome undergoing percutaneous coronary intervention. , 2013, Chinese medical journal.
[101] A. Akhmedov,et al. Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction. , 2013, Antioxidants & redox signaling.
[102] Tsuyoshi Watanabe,et al. Interaction between resistin and adiponectin in the proliferation of rat vascular smooth muscle cells , 2013, Molecular and Cellular Endocrinology.
[103] Juan Lei,et al. Association of higher resistin levels with inflammatory activation and endothelial dysfunction in patients with essential hypertension. , 2013, Chinese medical journal.
[104] S. B. Pedersen,et al. Acute exercise increases circulating inflammatory markers in overweight and obese compared with lean subjects , 2013, European Journal of Applied Physiology.
[105] T. Murohara,et al. Adipose‐derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[106] Huifeng Xu,et al. Association of serum resistin with peripheral arterial disease. , 2013, Polskie Archiwum Medycyny Wewnetrznej.
[107] B. Pedersen,et al. Human skeletal muscle releases leptin in vivo. , 2012, Cytokine.
[108] J. Pickering,et al. Intrinsic directionality of migrating vascular smooth muscle cells is regulated by NAD+ biosynthesis , 2012, Journal of Cell Science.
[109] J. Després,et al. Abdominal obesity and cardiovascular disease: is inflammation the missing link? , 2012, The Canadian journal of cardiology.
[110] T. N. Krogh,et al. Recombinant Adiponectin Does Not Lower Plasma Glucose in Animal Models of Type 2 Diabetes , 2012, PloS one.
[111] R. Virmani,et al. Leptin Locally Synthesized in Carotid Atherosclerotic Plaques Could Be Associated With Lesion Instability and Cerebral Emboli , 2012, Journal of the American Heart Association.
[112] H. Harashima,et al. RNA interference-based silencing reveals the regulatory role of fatty acid-binding protein 4 in the production of IL-6 and vascular endothelial growth factor in 3T3-L1 adipocytes. , 2012, Endocrinology.
[113] Yi-Chia Huang,et al. Relationships between Inflammation, Adiponectin, and Oxidative Stress in Metabolic Syndrome , 2012, PloS one.
[114] G. Werstuck,et al. Leptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3β. , 2012, Biochemical and biophysical research communications.
[115] V. Kakkar,et al. Relationship of adiponectin and leptin to coronary artery disease, classical cardiovascular risk factors and atherothrombotic biomarkers in the IARS cohort , 2012, Thrombosis and Haemostasis.
[116] B. Zhang,et al. Serum total adiponectin level and risk of cardiovascular disease in Han Chinese populations: a meta‐analysis of 17 case–control studies , 2012, Clinical endocrinology.
[117] R. Heshmat,et al. The association of carotid intima media thickness with retinol binding protein-4 and total and high molecular weight adiponectin in type 2 diabetic patients , 2012, Journal of Diabetes & Metabolic Disorders.
[118] K. Madan,et al. Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease , 2012, The Indian journal of medical research.
[119] Zhi-xin Guo,et al. Effects of adiponectin on oxidative stress and apoptosis in human cardiac myocytes cultured with high glucose. , 2012, Chinese medical journal.
[120] R. Adapala,et al. Upregulation of thrombospondin-1 expression by leptin in vascular smooth muscle cells via JAK2- and MAPK-dependent pathways. , 2012, American journal of physiology. Cell physiology.
[121] S. Allahverdian,et al. Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation. , 2012, Cardiovascular research.
[122] F. López‐Soriano,et al. Myostatin: more than just a regulator of muscle mass. , 2012, Drug discovery today.
[123] G. Norata,et al. Effect of Tie-2 conditional deletion of BDNF on atherosclerosis in the ApoE null mutant mouse. , 2012, Biochimica et biophysica acta.
[124] F. Cao,et al. Effects of ghrelin on homocysteine‐induced dysfunction and inflammatory response in rat cardiac microvascular endothelial cells , 2012, Cell biology international.
[125] M. Jonas,et al. Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques. , 2012, Atherosclerosis.
[126] A. Wrońska,et al. Structural and biochemical characteristics of various white adipose tissue depots , 2012, Acta physiologica.
[127] K. Feingold,et al. Angiopoietin like protein 4 expression is decreased in activated macrophages. , 2012, Biochemical and biophysical research communications.
[128] Bo Yang,et al. Resistin involved in endothelial dysfunction among preclinical Tibetan male young adults , 2012, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[129] L. Sturla,et al. NAD+ Levels Control Ca2+ Store Replenishment and Mitogen-induced Increase of Cytosolic Ca2+ by Cyclic ADP-ribose-dependent TRPM2 Channel Gating in Human T Lymphocytes* , 2012, The Journal of Biological Chemistry.
[130] H. Xie,et al. Ghrelin Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells through the ERK Pathway , 2012, PloS one.
[131] A. Lisowska,et al. Adiponectin--an independent marker of coronary artery disease occurrence rather than a degree of its advancement in comparison to the IMT values in peripheral arteries. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[132] C. Buechler,et al. CTRP family: linking immunity to metabolism , 2012, Trends in Endocrinology & Metabolism.
[133] D. Arveiler,et al. Adipocytokines and the risk of ischemic stroke: The PRIME Study , 2012, Annals of neurology.
[134] R. Sacco,et al. Adiponectin and Carotid Intima-Media Thickness in the Northern Manhattan Study , 2012, Stroke.
[135] Min Zhang,et al. Plasma ghrelin levels are closely associated with severity and morphology of angiographically-detected coronary atherosclerosis in Chineses patients with diabetes mellitus , 2012, Acta Pharmacologica Sinica.
[136] M. Whooley,et al. Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study. , 2012, Atherosclerosis.
[137] Q. Yao,et al. Resistin: functional roles and therapeutic considerations for cardiovascular disease , 2012, British journal of pharmacology.
[138] Yu Jin,et al. Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype. , 2012, Journal of molecular and cellular cardiology.
[139] D. Yavuz,et al. Serum adipokine levels in type 1 diabetic patients: association with carotid intima media thickness. , 2012, Metabolic syndrome and related disorders.
[140] C. Pepene. Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome , 2012, Clinical endocrinology.
[141] H. Tse,et al. Lipocalin‐2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibition , 2012, British journal of pharmacology.
[142] G. Kaushik,et al. Relationship of oxidative stress with obesity and its role in obesity induced metabolic syndrome. , 2012, Clinical laboratory.
[143] M. Altunbas,et al. Visfatin may be a novel marker for identifying stages of essential hypertension in advanced age patients. , 2012, Internal medicine.
[144] M. Fasshauer,et al. Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? , 2012, Diabetologia.
[145] H. J. Yoo,et al. Circulating chemerin level is independently correlated with arterial stiffness. , 2012, Journal of atherosclerosis and thrombosis.
[146] F. Violi,et al. Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome , 2012, Internal and Emergency Medicine.
[147] Weiqing Wang,et al. The association of serum chemerin level with risk of coronary artery disease in Chinese adults , 2012, Endocrine.
[148] M. Blüher. Vaspin in obesity and diabetes: pathophysiological and clinical significance , 2012, Endocrine.
[149] D. Atar,et al. Fatty Acid Binding Protein 4 Is Associated with Carotid Atherosclerosis and Outcome in Patients with Acute Ischemic Stroke , 2011, PloS one.
[150] D. Jacobs,et al. Obesity Modifies the Relations Between Serum Markers of Dairy Fats and Inflammation and Oxidative Stress Among Adolescents , 2011, Obesity.
[151] S. Kihara,et al. Circulating omentin is associated with coronary artery disease in men. , 2011, Atherosclerosis.
[152] M. Quon,et al. Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-κB/COX-2 signaling in human aortic endothelial cells. , 2011, American journal of physiology. Endocrinology and metabolism.
[153] H. J. Yoo,et al. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes , 2011, Cardiovascular diabetology.
[154] S. Kihara,et al. Fat-derived Factor Omentin Stimulates Endothelial Cell Function and Ischemia-induced Revascularization via Endothelial Nitric Oxide Synthase-dependent Mechanism* , 2011, The Journal of Biological Chemistry.
[155] T. Romacho,et al. Visfatin Impairs Endothelium-Dependent Relaxation in Rat and Human Mesenteric Microvessels through Nicotinamide Phosphoribosyltransferase Activity , 2011, PloS one.
[156] S. Kwak,et al. Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women , 2011, Clinical endocrinology.
[157] J. Manson,et al. Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. , 2011, Atherosclerosis.
[158] S. Tang,et al. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. , 2011, Cardiovascular research.
[159] Yajing Wang,et al. C1q/TNF-Related Proteins, A Family of Novel Adipokines, Induce Vascular Relaxation Through the Adiponectin Receptor-1/AMPK/eNOS/Nitric Oxide Signaling Pathway , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[160] P. Aukrust,et al. Nicotinamide phosphoribosyltransferase and lipid accumulation in macrophages , 2011, European journal of clinical investigation.
[161] H. Lam,et al. Elevated serum retinol-binding protein 4 concentrations are associated with chronic kidney disease but not with the higher carotid intima-media thickness in type 2 diabetic subjects. , 2011, Endocrine journal.
[162] Xinhua Xiao,et al. Adiponectin protects endothelial cells from the damages induced by the intermittent high level of glucose , 2011, Endocrine.
[163] Min Zhang,et al. Plasma ghrelin levels are closely associated with stenosis severity and morphology of angiographically-detected coronary atherosclerosis in patients with coronary artery disease. , 2011, International journal of cardiology.
[164] T. Murohara,et al. Adipolin/C1qdc2/CTRP12 Protein Functions as an Adipokine That Improves Glucose Metabolism* , 2011, The Journal of Biological Chemistry.
[165] E. Vittinghoff,et al. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study. , 2011, Atherosclerosis.
[166] J. Moreno-Navarrete,et al. Circulating Omentin as a Novel Biomarker of Endothelial Dysfunction , 2011, Obesity.
[167] Hong-Yu Zhao,et al. Globular adiponectin protects human umbilical vein endothelial cells against apoptosis through adiponectin receptor 1/adenosine monophosphate-activated protein kinase pathway. , 2011, Chinese medical journal.
[168] Ihsan Kaya,et al. Impact of contrast enhanced MRI on lymphocyte DNA damage and serum visfatin level. , 2011, Clinical biochemistry.
[169] J. Després,et al. Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study). , 2011, The American journal of cardiology.
[170] P. Wilson,et al. Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study. , 2011, Atherosclerosis.
[171] H. Volk,et al. Adiponectin is a negative regulator of antigen‐activated T cells , 2011, European journal of immunology.
[172] Li Li,et al. Adiponectin Upregulates Prolyl-4-Hydroxylase α1 Expression in Interleukin 6-Stimulated Human Aortic Smooth Muscle Cells by Regulating ERK 1/2 and Sp1 , 2011, PloS one.
[173] Hiroshi Takahashi,et al. Association of Adiponectin with Carotid Arteriosclerosis in Predialysis Chronic Kidney Disease , 2011, American Journal of Nephrology.
[174] Peili Bu,et al. Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. , 2011, Diabetes research and clinical practice.
[175] T. Lehtimäki,et al. A longitudinal analysis on associations of adiponectin levels with metabolic syndrome and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study. , 2011, Atherosclerosis.
[176] K. Hino,et al. High-Throughput Screening for Small-Molecule Adiponectin Secretion Modulators , 2011, Journal of biomolecular screening.
[177] J. B. Dichi,et al. Immunological and biochemical parameters of patients with metabolic syndrome and the participation of oxidative and nitroactive stress. , 2011, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[178] T. Rohan,et al. Resistin, but Not Adiponectin and Leptin, Is Associated With the Risk of Ischemic Stroke Among Postmenopausal Women: Results From the Women's Health Initiative , 2011, Stroke.
[179] S. Watanabe,et al. Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes. , 2011, Endocrinology.
[180] M. Sabatine,et al. Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22). , 2011, American heart journal.
[181] H. Markus,et al. Adiponectin Level as a Consequence of Genetic Variation, but Not Leptin Level or Leptin: Adiponectin Ratio, Is a Risk Factor for Carotid Intima-Media Thickness , 2011, Stroke.
[182] Yi Zhou,et al. Association of serum omentin-1 levels with coronary artery disease , 2011, Acta Pharmacologica Sinica.
[183] J. Tardif,et al. Functional Effects of Adiponectin on Endothelial Progenitor Cells , 2011, Obesity.
[184] A. Xu,et al. Chronic administration of BMS309403 improves endothelial function in apolipoprotein E‐deficient mice and in cultured human endothelial cells , 2011, British journal of pharmacology.
[185] Ling-Qing Yuan,et al. Apelin Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells , 2011, PloS one.
[186] W. Zeng,et al. Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease. , 2011, Journal of nephrology.
[187] Wei Wang,et al. Ghrelin inhibits AGEs‐induced apoptosis in human endothelial cells involving ERK1/2 and PI3K/Akt pathways , 2011, Cell biochemistry and function.
[188] C. Buechler,et al. Globular and full-length adiponectin induce NO-dependent vasodilation in resistance arteries of Zucker lean but not Zucker diabetic fatty rats. , 2011, American journal of hypertension.
[189] A. Gabrielsen,et al. Expression of fatty acid–binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis , 2011, Journal of internal medicine.
[190] J. Després,et al. Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women. , 2011, European heart journal.
[191] H. Vargas-Robles,et al. Correlation between circulating adhesion molecules and resistin levels in hypertensive type-2 diabetic patients. , 2011, Inflammation & allergy drug targets.
[192] G. Kottas,et al. Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[193] J. Kasprzak,et al. Elevated resistin opposed to adiponectin or angiogenin plasma levels as a strong, independent predictive factor for the occurrence of major adverse cardiac and cerebrovascular events in patients with stable multivessel coronary artery disease over 1-year follow-up , 2011, Medical science monitor : international medical journal of experimental and clinical research.
[194] M. Whooley,et al. Association of resistin with heart failure and mortality in patients with stable coronary heart disease: data from the heart and soul study. , 2011, Journal of cardiac failure.
[195] Reiko Ohmori,et al. Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention. , 2011, Journal of atherosclerosis and thrombosis.
[196] H. Randeva,et al. Diurnal variation and effect of insulin on circulating high molecular weight (HMW) adiponectin and NF-κB activity in human endothelial cells. , 2011, Atherosclerosis.
[197] S. Kusachi,et al. Association of circulating levels of leptin and adiponectin with metabolic syndrome and coronary heart disease in patients with various coronary risk factors. , 2011, International heart journal.
[198] S. Tang,et al. Omentin inhibits osteoblastic differentiation of calcifying vascular smooth muscle cells through the PI3K/Akt pathway , 2011, Amino Acids.
[199] M. Stumvoll,et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans , 2011, Diabetologia.
[200] A. Pfeiffer,et al. Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. , 2010, Atherosclerosis.
[201] S. Bessa,et al. Serum visfatin as a non-traditional biomarker of endothelial dysfunction in chronic kidney disease: an Egyptian study. , 2010, European journal of internal medicine.
[202] N. Sarrafzadegan,et al. Relationship Between Carotid Intima-Media Thickness with some Inflammatory Biomarkers, Ghrelin and Adiponectin in Iranians with and without Metabolic Syndrome in Isfahan Cohort Study , 2010, ARYA atherosclerosis.
[203] R. Huupponen,et al. Adiponectin is related with carotid artery intima-media thickness and brachial flow-mediated dilatation in young adults—The Cardiovascular Risk in Young Finns Study , 2010, Annals of medicine.
[204] D. Serena,et al. Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients , 2010 .
[205] G. Aragonès,et al. Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes. , 2010, Atherosclerosis.
[206] A. Yildiz,et al. [The levels of the leptin and adiponectin according to body mass index and their relationship with oxidative parameters]. , 2010, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.
[207] J. Schölmerich,et al. C1q/TNF-related protein-3 represents a novel and endogenous lipopolysaccharide antagonist of the adipose tissue. , 2010, Endocrinology.
[208] Lawrence Joseph,et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.
[209] M. Al-Omran,et al. Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. , 2010, American journal of physiology. Heart and circulatory physiology.
[210] A. Xu,et al. Adiponectin Prevents Diabetic Premature Senescence of Endothelial Progenitor Cells and Promotes Endothelial Repair by Suppressing the p38 MAP Kinase/p16INK4A Signaling Pathway , 2010, Diabetes.
[211] G. Dallinga-Thie,et al. Carotid intima media thickness is associated with plasma adiponectin but not with the leptin:adiponectin ratio independently of metabolic syndrome. , 2010, Atherosclerosis.
[212] F. Hu,et al. Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. , 2010, European journal of endocrinology.
[213] Seung-Yoon Park,et al. C1qTNF-related protein-6 increases the expression of interleukin-10 in macrophages , 2010, Molecules and cells.
[214] P. Lin,et al. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. , 2010, American journal of physiology. Heart and circulatory physiology.
[215] L. Ferrucci,et al. Influence of leptin, adiponectin, and resistin on the association between abdominal adiposity and arterial stiffness. , 2010, American journal of hypertension.
[216] C. Smas,et al. Downregulated expression of the secreted glycoprotein follistatin-like 1 (Fstl1) is a robust hallmark of preadipocyte to adipocyte conversion , 2010, Mechanisms of Development.
[217] C. Meisinger,et al. Leptin, adiponectin, their ratio and risk of Coronary Heart Disease: results from the MONICA/KORA Augsburg Study 1984-2002. , 2010, Atherosclerosis.
[218] J. Małyszko,et al. Visfatin and endothelial function in dialyzed patients , 2010, Nephrology.
[219] E. Maury,et al. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome , 2010, Molecular and Cellular Endocrinology.
[220] C. Liapis,et al. Visfatin (Nampt) and Ghrelin as Novel Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[221] V. Hombach,et al. Resistin: a newly identified chemokine for human CD4-positive lymphocytes. , 2010, Cardiovascular research.
[222] E. Onur,et al. Factors affecting carotid intima media thickness predicts early atherosclerosis in overweight and obese adolescents. , 2010, Obesity research & clinical practice.
[223] C. Bai,et al. Low serum acylated ghrelin levels are associated with the development of cardiovascular disease in hemodialysis patients. , 2010, Internal medicine.
[224] D. Arveiler,et al. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study , 2010, International Journal of Obesity.
[225] G. Sweeney. Cardiovascular effects of leptin , 2010, Nature Reviews Cardiology.
[226] C. Mantzoros,et al. Adiponectin in insulin resistance: lessons from translational research. , 2010, The American journal of clinical nutrition.
[227] C. Richart,et al. Macrophages are novel sites of expression and regulation of retinol binding protein-4 (RBP4). , 2010, Physiological research.
[228] Y. Moon,et al. Resistin enhances the expansion of regulatory T cells through modulation of dendritic cells , 2010, BMC Immunology.
[229] A. Schutte,et al. Ethnic‐specific Correlations of Visfatin With Circulating Markers of Endothelial Inflammation and Function , 2009, Obesity.
[230] Qingbo Xu,et al. Homocysteine promotes vascular smooth muscle cell migration by induction of the adipokine resistin. , 2009, American journal of physiology. Cell physiology.
[231] A. Ballestrero,et al. Catastrophic NAD+ Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE , 2009, PloS one.
[232] W. Wahli,et al. A Concerted Kinase Interplay Identifies PPARγ as a Molecular Target of Ghrelin Signaling in Macrophages , 2009, PloS one.
[233] K. Shyu,et al. Regulation of resistin by cyclic mechanical stretch in cultured rat vascular smooth muscle cells. , 2009, Clinical science.
[234] P. He,et al. [Ghrelin down-regulates ACAT-1 in THP-1 derived foam cells via growth hormone secretagogue receptor-dependent pathway]. , 2009, Zhonghua xin xue guan bing za zhi.
[235] Y. Caliskan,et al. Plasma Ghrelin Levels Are Associated with Coronary Microvascular and Endothelial Dysfunction in Peritoneal Dialysis Patients , 2009, Renal failure.
[236] Y. Hattori,et al. Induction of gene expression in response to globular adiponectin in vascular endothelial cells. , 2009, Life sciences.
[237] L. Rodríguez-Mañas,et al. Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity , 2009, Diabetologia.
[238] Masahide Takahashi,et al. Adiponectin promotes migration activities of endothelial progenitor cells via Cdc42/Rac1 , 2009, FEBS letters.
[239] Dong Liu,et al. Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans , 2009, Clinical endocrinology.
[240] M. Reiser,et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. , 2009, European journal of endocrinology.
[241] P. Libby,et al. Adiponectin Inhibits Pro-inflammatory Signaling in Human Macrophages Independent of Interleukin-10* , 2009, The Journal of Biological Chemistry.
[242] M. Whooley,et al. Adiponectin and inducible ischemia in patients with stable coronary heart disease: data from the Heart and Soul study. , 2009, Atherosclerosis.
[243] A. Falus,et al. The major inflammatory mediator interleukin-6 and obesity , 2009, Inflammation Research.
[244] K. Kario,et al. Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients. , 2009, Atherosclerosis.
[245] E. Kang,et al. Retinol-binding protein-4 is associated with endothelial dysfunction in adults with newly diagnosed type 2 diabetes mellitus. , 2009, Atherosclerosis.
[246] P. Greaney,et al. The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies. , 2009, Blood.
[247] M. Viora,et al. Leptin exerts an anti‐apoptotic effect on human dendritic cells via the PI3K‐Akt signaling pathway , 2009, FEBS letters.
[248] N. Manley,et al. Deficient Ghrelin Receptor-mediated Signaling Compromises Thymic Stromal Cell Microenvironment by Accelerating Thymic Adiposity* , 2009, Journal of Biological Chemistry.
[249] S. Ishikawa,et al. Plasma Adiponectin Level and Myocardial Infarction: the JMS Cohort Study , 2009, Journal of epidemiology.
[250] M. J. Bianco,et al. Ghrelin inhibits contraction and proliferation of human aortic smooth muscle cells by cAMP/PKA pathway activation. , 2009, Atherosclerosis.
[251] T. Tamaki,et al. Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells , 2009, Hypertension Research.
[252] S. Yamashita,et al. Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis. , 2009, Biochemical and biophysical research communications.
[253] N. Sattar,et al. Adipocytokines and risk of stroke in older people: a nested case-control study. , 2009, International journal of epidemiology.
[254] D. Su,et al. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. , 2009, Cardiovascular research.
[255] Y. Jang,et al. Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry , 2009, Coronary artery disease.
[256] Peng Zhang,et al. Overexpression of Adiponectin Receptors Potentiates the Antiinflammatory Action of Subeffective Dose of Globular Adiponectin in Vascular Endothelial Cells , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[257] K. Clément,et al. Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. , 2009, The Journal of clinical endocrinology and metabolism.
[258] L. Tian,et al. Adiponectin reduces lipid accumulation in macrophage foam cells. , 2009, Atherosclerosis.
[259] K. Fukuo,et al. Relationships of systemic oxidative stress to body fat distribution, adipokines and inflammatory markers in healthy middle-aged women. , 2009, Endocrine journal.
[260] J. Ye. Emerging role of adipose tissue hypoxia in obesity and insulin resistance , 2009, International Journal of Obesity.
[261] A. Tonkin,et al. Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study , 2009, International Journal of Obesity.
[262] Geng Xu,et al. Adiponectin levels are associated with the number and activity of circulating endothelial progenitor cells in patients with coronary artery disease , 2009, Journal of Zhejiang University SCIENCE B.
[263] D. Levy,et al. Plasma Leptin Levels and Incidence of Heart Failure, Cardiovascular Disease, and Total Mortality in Elderly Individuals , 2008, Diabetes Care.
[264] Yuan Zhang,et al. Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signaling Mechanism* , 2008, Journal of Biological Chemistry.
[265] T. Funahashi,et al. Plasma Adiponectin: A Predictor of Coronary Heart Disease in Hemodialysis Patients – A Japanese Prospective Eight-Year Study , 2008, Nephron Clinical Practice.
[266] G. Lip,et al. Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function , 2008, Journal of internal medicine.
[267] H. Gong,et al. Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis , 2008, Clinical endocrinology.
[268] K. Shyu,et al. The molecular regulation of resistin expression in cultured vascular smooth muscle cells under hypoxia , 2008, Journal of hypertension.
[269] S. Omura,et al. Upregulation of Heme Oxygenase-1 Combined with Increased Adiponectin Lowers Blood Pressure in Diabetic Spontaneously Hypertensive Rats through a Reduction in Endothelial Cell Dysfunction, Apoptosis and Oxidative Stress , 2008, International journal of molecular sciences.
[270] S. Kihara,et al. Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages. , 2008, Biochemical and biophysical research communications.
[271] F. Andris,et al. Nicotinamide Phosphoribosyl Transferase/Pre-B Cell Colony-Enhancing Factor/Visfatin Is Required for Lymphocyte Development and Cellular Resistance to Genotoxic Stress1 , 2008, The Journal of Immunology.
[272] L. Kuller,et al. Adiponectin and risk of coronary heart disease in older men and women. , 2008, Journal of Clinical Endocrinology and Metabolism.
[273] X. Qiu,et al. Inhibition of proliferation and apoptosis of vascular smooth muscle cells by ghrelin. , 2008, Acta biochimica et biophysica Sinica.
[274] Xiangbin Xu,et al. Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. , 2008, Endocrinology.
[275] E. Rimm,et al. Plasma resistin levels and risk of myocardial infarction and ischemic stroke. , 2008, The Journal of clinical endocrinology and metabolism.
[276] Y. Hattori,et al. Adiponectin induces NF-κB activation that leads to suppression of cytokine-induced NF-κB activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin , 2008, Diabetes & vascular disease research.
[277] P. Elder,et al. Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins , 2008, Diabetes & vascular disease research.
[278] S. Kihara,et al. Adiponectin promotes endothelial progenitor cell number and function , 2008, FEBS Letters.
[279] D. Lawlor,et al. High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study. , 2008, The Journal of clinical endocrinology and metabolism.
[280] Russell A. Carter,et al. Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots , 2008, International Journal of Obesity.
[281] Y. Ouchi,et al. Adiponectin antagonizes stimulatory effect of tumor necrosis factor-alpha on vascular smooth muscle cell calcification: regulation of growth arrest-specific gene 6-mediated survival pathway by adenosine 5'-monophosphate-activated protein kinase. , 2008, Endocrinology.
[282] Z. Malam,et al. Pre‐B cell colony‐enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity , 2008, Journal of leukocyte biology.
[283] Y. Jang,et al. Association between serum resistin and carotid intima media thickness in hypertension patients. , 2008, International journal of cardiology.
[284] S. Katergari,et al. Ghrelin in pathological conditions. , 2008, Endocrine journal.
[285] S. Ashley,et al. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. , 2008, Surgery.
[286] S. Ishikawa,et al. Association of Adiponectin With Cerebrovascular Disease: A Nested Case–Control Study , 2008, Stroke.
[287] H. Seo,et al. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. , 2008, European journal of endocrinology.
[288] P. Libby,et al. Adiponectin Inhibits the Production of CXC Receptor 3 Chemokine Ligands in Macrophages and Reduces T-Lymphocyte Recruitment in Atherogenesis , 2008, Circulation research.
[289] M. Päivänsalo,et al. Interactions between ghrelin, leptin and IGF-I affect metabolic syndrome and early atherosclerosis , 2008, Annals of medicine.
[290] H. Brenner,et al. Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. , 2007, European heart journal.
[291] M. Tabata,et al. The role of angiopoietin-like proteins in angiogenesis and metabolism. , 2008, Trends in cardiovascular medicine.
[292] Sun Wook Cho,et al. Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study. , 2008, Atherosclerosis.
[293] K. Clément,et al. Defective Leptin/Leptin Receptor Signaling Improves Regulatory T Cell Immune Response and Protects Mice From Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[294] Chieh-Hsi Wu,et al. Leptin stimulates endothelin-1 expression via extracellular signal-regulated kinase by epidermal growth factor receptor transactivation in rat aortic smooth muscle cells. , 2007, European journal of pharmacology.
[295] A. Weeraratna,et al. Ghrelin promotes thymopoiesis during aging. , 2007, The Journal of clinical investigation.
[296] S. Javadov,et al. Actin Cytoskeleton Dynamics Promotes Leptin-Induced Vascular Smooth Muscle Hypertrophy via RhoA/ROCK- and Phosphatidylinositol 3-Kinase/Protein Kinase B-Dependent Pathways , 2007, Journal of Pharmacology and Experimental Therapeutics.
[297] Tsai-Kun Wu,et al. Association of Plasma Adiponectin Levels with Oxidative Stress in Hemodialysis Patients , 2007, Blood Purification.
[298] T. Akasaka,et al. Effects of plasma adiponectin levels on the number and function of endothelial progenitor cells in patients with coronary artery disease. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[299] V. Somers,et al. Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population. , 2007, The American journal of cardiology.
[300] M. Fasshauer,et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. , 2007, Cell metabolism.
[301] A. Bosutti,et al. Low fat adiponectin expression is associated with oxidative stress in nondiabetic humans with chronic kidney disease--impact on plasma adiponectin concentration. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.
[302] Yu Huang,et al. Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. , 2007, Cardiovascular research.
[303] I. Kallikazaros,et al. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. , 2007, European heart journal.
[304] W. Sluiter,et al. Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender. , 2007, European journal of endocrinology.
[305] R. Walker,et al. Vitamin E Supplementation and Plasma 8‐Isoprostane and Adiponectin in Overweight Subjects , 2007, Obesity.
[306] C. Berne,et al. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. , 2007, The Journal of clinical endocrinology and metabolism.
[307] E. Barrett-Connor,et al. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. , 2006, American journal of epidemiology.
[308] R. Schnabel,et al. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. , 2006, Atherosclerosis.
[309] A. Leicht,et al. Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication. , 2007, Journal of vascular surgery.
[310] Weibin Xu,et al. Resistin increases lipid accumulation and CD36 expression in human macrophages. , 2006, Biochemical and biophysical research communications.
[311] S. Cummings,et al. Serum adiponectin and coronary heart disease risk in older Black and White Americans. , 2006, The Journal of clinical endocrinology and metabolism.
[312] Xuetao Cao,et al. Involvement of leptin signaling in the survival and maturation of bone marrow‐derived dendritic cells , 2006, European journal of immunology.
[313] W. Wahli,et al. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway. , 2006, Molecular endocrinology.
[314] C. Meisinger,et al. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. , 2006, Journal of the American College of Cardiology.
[315] T. Ogihara,et al. Adiponectin and inflammatory markers in peripheral arterial occlusive disease. , 2006, Atherosclerosis.
[316] K. Kotani,et al. Serum ghrelin and carotid atherosclerosis in older Japanese people with metabolic syndrome. , 2006, Archives of medical research.
[317] E. Gabazza,et al. Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance. , 2006, Diabetes research and clinical practice.
[318] J. Danesh,et al. Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis , 2006, Circulation.
[319] J. Shiloach,et al. MKR mice are resistant to the metabolic actions of both insulin and adiponectin: discordance between insulin resistance and adiponectin responsiveness. , 2006, American journal of physiology. Endocrinology and metabolism.
[320] J. H. Lee,et al. Insulin resistance, adipokines, and oxidative stress in nondiabetic, hypercholesterolemic patients: leptin as an 8-epi-prostaglandin F2alpha determinant. , 2006, Metabolism: clinical and experimental.
[321] M. Päivänsalo,et al. Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males , 2006, Journal of internal medicine.
[322] P. Scherer,et al. Adipose tissue-derived factors: impact on health and disease. , 2006, Endocrine reviews.
[323] J. Schneider,et al. Serum adiponectin levels are an independent predictor of the extent of coronary artery disease in men. , 2006, Journal of the American College of Cardiology.
[324] B. O'dowd,et al. Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. , 2006, Trends in pharmacological sciences.
[325] D. Jacobs,et al. Adiponectin, Visceral Fat, Oxidative Stress, and Early Macrovascular Disease: The Coronary Artery Risk Development in Young Adults Study , 2006, Obesity.
[326] M. Fasshauer,et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. , 2006, Biochemical and biophysical research communications.
[327] Y. Hattori,et al. Globular adiponectin activates nuclear factor-kappaB in vascular endothelial cells, which in turn induces expression of proinflammatory and adhesion molecule genes. , 2006, Diabetes care.
[328] K. Park,et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. , 2006, Cardiovascular research.
[329] S. Kihara,et al. Adiponectin Inhibits Endothelial Synthesis of Interleukin-8 , 2005, Circulation research.
[330] P. Meda,et al. Production of Chemokines by Perivascular Adipose Tissue: A Role in the Pathogenesis of Atherosclerosis? , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[331] S. Javadov,et al. Leptin Induces Vascular Smooth Muscle Cell Hypertrophy through Angiotensin II- and Endothelin-1-Dependent Mechanisms and Mediates Stretch-Induced Hypertrophy , 2005, Journal of Pharmacology and Experimental Therapeutics.
[332] D. Lauro,et al. Ghrelin Improves Endothelial Function in Patients With Metabolic Syndrome , 2005, Circulation.
[333] H. Brenner,et al. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. , 2005, European heart journal.
[334] C. Pan,et al. Ghrelin blunted vascular calcification in vivo and in vitro in rats , 2005, Regulatory Peptides.
[335] J. Pickering,et al. Pre–B-Cell Colony–Enhancing Factor Regulates NAD+-Dependent Protein Deacetylase Activity and Promotes Vascular Smooth Muscle Cell Maturation , 2005, Circulation research.
[336] S. Archer. Pre–B-cell Colony-Enhancing Factor Regulates Vascular Smooth Muscle Maturation Through a NAD+-Dependent Mechanism: Recognition of a New Mechanism for Cell Diversity and Redox Regulation of Vascular Tone and Remodeling , 2005, Circulation research.
[337] N. Wiernsperger,et al. Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. , 2005, Diabetes.
[338] E. Straface,et al. Leptin Promotes Differentiation and Survival of Human Dendritic Cells and Licenses Them for Th1 Priming 1 , 2005, The Journal of Immunology.
[339] J. H. Lee,et al. Leptin induces hypertrophy via p38 mitogen-activated protein kinase in rat vascular smooth muscle cells. , 2005, Biochemical and biophysical research communications.
[340] J. Skepper,et al. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells , 2005, Regulatory Peptides.
[341] B. Howard,et al. Adiponectin and coronary heart disease: the Strong Heart Study. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[342] N. Kohno,et al. A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. , 2005, Metabolism: clinical and experimental.
[343] E. Rimm,et al. Adiponectin and future coronary heart disease events among men with type 2 diabetes. , 2005, Diabetes.
[344] Yan Zheng,et al. Effects of ghrelin on the proliferation and secretion of splenic T lymphocytes in mice , 2004, Regulatory Peptides.
[345] Bruce D. Johnson,et al. Plasma leptin and prognosis in patients with established coronary atherosclerosis. , 2004, Journal of the American College of Cardiology.
[346] L. Weinehall,et al. Leptin, but not adiponectin, predicts stroke in males , 2004, Journal of internal medicine.
[347] D. Taub,et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. , 2004, The Journal of clinical investigation.
[348] Cynthia J. Girman,et al. Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.
[349] H. Motoshima,et al. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. , 2004, Biochemical and biophysical research communications.
[350] S. Kihara,et al. Selective Suppression of Endothelial Cell Apoptosis by the High Molecular Weight Form of Adiponectin , 2004, Circulation research.
[351] R. Nagai,et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. , 2004, Biochemical and biophysical research communications.
[352] M. Fiore,et al. Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? , 2004, Progress in brain research.
[353] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[354] Marc Parmentier,et al. Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids , 2003, The Journal of experimental medicine.
[355] L. Luzi,et al. Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. , 2003, Diabetes care.
[356] Joanna D. Holbrook,et al. Resistin is expressed in human macrophages and directly regulated by PPARγ activators , 2003 .
[357] R. Sun,et al. Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. , 2003, Biochemical and biophysical research communications.
[358] S. Kihara,et al. Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[359] D. Gigot,et al. Pre‐B‐cell colony‐enhancing factor, whose expression is up‐regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis , 2002, European journal of immunology.
[360] S. Kihara,et al. Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell , 2002, Circulation.
[361] S. Kihara,et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[362] N. Sattar,et al. Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) , 2001, Circulation.
[363] M. Fujimiya,et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism , 2001, Regulatory Peptides.
[364] P. Rizzon,et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery , 2001, International Journal of Obesity.
[365] M. Yokoyama,et al. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. , 2001, The Kobe journal of medical sciences.
[366] B. Spiegelman,et al. Peroxisome Proliferator-Activated Receptor γ Target Gene Encoding a Novel Angiopoietin-Related Protein Associated with Adipose Differentiation , 2000, Molecular and Cellular Biology.
[367] T. Olsson,et al. Leptin is associated with increased risk of myocardial infarction , 1999, Journal of internal medicine.
[368] G. Dagenais,et al. Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study , 1998, Diabetes Care.
[369] T. Funahashi,et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.
[370] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.